chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dyspnoea, Exposure to SARS-CoV-2, Hypophagia, Weight decreased
Clinical narrative: A 77-year-old male with history of COPD, CAD, DMT2, HTN presented with a chief complaint of shortness of breath and severe wheezing over the last 3-4 days. Patient stated he had a severe drop of weight (loss 30 pounds over the last year), which he is concerned about. He felt very weak. He denied any other symptoms. He was taken out of his home due to his roommate being positive w/COVID-19 and directed to go to the ED today by his PCP. Patient stated he has not been eating much for a while.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: A 77-year-old male with history of COPD, CAD, DMT2, HTN presented with a chief complaint of shortness of breath and severe wheezing over the last 3-4 days. Patient stated he had a severe drop of weight (loss 30 pounds over the last year), which he is concerned about. He felt very weak. He denied any other symptoms. He was taken out of his home due to his roommate being positive w/COVID-19 and directed to go to the ED today by his PCP. Patient stated he has not been eating much for a while.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site infection, Injection site scab, Pain in extremity, Pyrexia
Clinical narrative: Patient described pain and soreness in upper arm one week after receiving injection as well as fever and chills. Used Neosporin on area. Doctor visit 11/23/2021: Injection site has small scab. Noticed infection without any surrounding erythema. Mildly tender to palpation. Rest of arm exam unremarkable with good range of motion.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Incorrect Dose Moderna booster dose administered was 0.5 milliliters. Booster dose should have been 0.25 milliliters.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Incorrect Dose Moderna booster dose administered was 0.5 milliliters. Booster dose should have been 0.25 milliliters.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient presented to the office for her Moderna booster vaccine (0.25 mL). It was brought to the attention of the vaccine manager, that the efficacy of the vaccines being administered that morning was diminished due to the length of time that the vaccine vial had been open for. The vial had been open for 24 hours at that point in time. The patient stayed under standard observation for 15 minutes and exhibited no ill effects.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Headache, SARS-CoV-2 test positive
Clinical narrative: symptoms x 1 week - H/A, short of breath, 4L O2
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Heart rate increased, Loss of consciousness, Nausea
Clinical narrative: Fever >100.0, nauseaus, dizziness, chest pain, fast hart rate. Eventually lost consciousness while driving and got into a car accident.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Road traffic accident
Clinical narrative: Fever >100.0, nauseaus, dizziness, chest pain, fast hart rate. Eventually lost consciousness while driving and got into a car accident.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Incorrect Dose Moderna booster dose administered was 0.5 milliliters. Booster dose should have been 0.25 milliliters.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE STORED AT IMPROPER TEMPERATURE.
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine that was administered to the patient was given 23 hours after dilution (per manufacturer guideline should only be administered up to 12 hours after dilution).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, Atrial fibrillation, COVID-19, Cerebral ischaemia, Computerised tomogram head abnormal
Clinical narrative: This is a 70y.o. female who presents to ER due to altered mental status and difficulty with word finding. The family found the patient is dysarthric and aphasic and she was brought to the emergency department via EMS. Overnight her speech has improved. A CT of the brain with stroke protocol was consistent with early/subacute ischemia involving the left insular cortex?left MCA distribution. She was initially normal sinus rhythm overnight went into atrial fibrillation. Additionally, she tested positive for COVID-19 on 10 4 urgent care. She is vaccinated ×2 with the Pfizer vaccine, and had been in the process of getting set up for posterior she tested positive. She did receive monoclonal antibody treatment.   This morning the patient denies any new complaints. Her breathing is at baseline. She reports that her speech is approximately 80% better.   Cardiology and neurology on consult   I spoke with the patient's daughter who assisted with additional history
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dysarthria, Ischaemia, Mental status changes, SARS-CoV-2 test positive, Sinus rhythm
Clinical narrative: This is a 70y.o. female who presents to ER due to altered mental status and difficulty with word finding. The family found the patient is dysarthric and aphasic and she was brought to the emergency department via EMS. Overnight her speech has improved. A CT of the brain with stroke protocol was consistent with early/subacute ischemia involving the left insular cortex?left MCA distribution. She was initially normal sinus rhythm overnight went into atrial fibrillation. Additionally, she tested positive for COVID-19 on 10 4 urgent care. She is vaccinated ×2 with the Pfizer vaccine, and had been in the process of getting set up for posterior she tested positive. She did receive monoclonal antibody treatment.   This morning the patient denies any new complaints. Her breathing is at baseline. She reports that her speech is approximately 80% better.   Cardiology and neurology on consult   I spoke with the patient's daughter who assisted with additional history
Age: 31.0
Sex: M
Vaccine: TDAP
Symptoms: Arthralgia, Impaired work ability, Injection site pain, Limb discomfort, Muscular weakness
Clinical narrative: See next page
Age: 31.0
Sex: M
Vaccine: TDAP
Symptoms: Neck pain, Pain in extremity, Paraesthesia, Product administered at inappropriate site, Wrong technique in product usage process
Clinical narrative: See next page
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chondrocalcinosis pyrophosphate, Gait inability, Synovial fluid crystal present
Clinical narrative: PSEUDO-GOUT  DIAGNOSIS AFTER MY SECOND SHOT.    I WAS WALKING WELL AND EVEN RUNNING A LITTLE A FEW MONTHS AFTER MY KNEE SURGERY. AFTER MY FIRST SHOT MY KNEE STARTED TO BOTHER ME AFTER THE SECOND SHOT I COULD NOT WALK. I THOUGHT I WORKED IT TOO HARD BUT THEY FOUND CALCIUM PYROPHOSATE CRYSTALS IN THE FLUID AROUND MY KNEE.   I am not alone. The pro ball player caught it too.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: Covid positive household contact
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Bowel movement irregularity, COVID-19, Chest X-ray, Chills, Cough
Clinical narrative: Patient developed extreme fatigue x 12 hours on 10/302021.  Took tylenol and started feeling okay, at 5pm she started having chills and fever of 102.  Had fatigue after this that lasted the whole weekend.  She called her doctor on 11/1, fever subsided, but she was exhausted.  On 11/3 she had a cough with cold symptoms and she went to Urgent care to be evaluated.  11/4 she had a loss of appetite with 3 "weird" bowel movements, metallic taste.  She was advised to go to Health Center and get a COVID-19 test.  Had history of COVID 19 in 2020.  11/5 results of Covid Test were positive/detected for the virus.  Advised to stay home for isolation period, call doctor about symptoms and test results.  Got pulse oximeter- 97-98%.  11/10 Dr. prescribed prednisone medication because she was still coughing.  11/12 started feeling better
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dysgeusia, Fatigue, Laboratory test, Nasopharyngitis
Clinical narrative: Patient developed extreme fatigue x 12 hours on 10/302021.  Took tylenol and started feeling okay, at 5pm she started having chills and fever of 102.  Had fatigue after this that lasted the whole weekend.  She called her doctor on 11/1, fever subsided, but she was exhausted.  On 11/3 she had a cough with cold symptoms and she went to Urgent care to be evaluated.  11/4 she had a loss of appetite with 3 "weird" bowel movements, metallic taste.  She was advised to go to Health Center and get a COVID-19 test.  Had history of COVID 19 in 2020.  11/5 results of Covid Test were positive/detected for the virus.  Advised to stay home for isolation period, call doctor about symptoms and test results.  Got pulse oximeter- 97-98%.  11/10 Dr. prescribed prednisone medication because she was still coughing.  11/12 started feeling better
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient developed extreme fatigue x 12 hours on 10/302021.  Took tylenol and started feeling okay, at 5pm she started having chills and fever of 102.  Had fatigue after this that lasted the whole weekend.  She called her doctor on 11/1, fever subsided, but she was exhausted.  On 11/3 she had a cough with cold symptoms and she went to Urgent care to be evaluated.  11/4 she had a loss of appetite with 3 "weird" bowel movements, metallic taste.  She was advised to go to Health Center and get a COVID-19 test.  Had history of COVID 19 in 2020.  11/5 results of Covid Test were positive/detected for the virus.  Advised to stay home for isolation period, call doctor about symptoms and test results.  Got pulse oximeter- 97-98%.  11/10 Dr. prescribed prednisone medication because she was still coughing.  11/12 started feeling better
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE STORED AT IMPROPER TEMPERATURES,
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Incorrect Dose Moderna booster dose administered was 0.5 milliliters. Booster dose should have been 0.25 milliliters.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Grip strength decreased, Muscular weakness, Myositis, Pain in extremity
Clinical narrative: I received my second dose of Moderna on 3/9/2021. On about 3/23/2021 at some time in the morning, I had pain in both hands. At first, the pain was more intense in the right hand, but over time the pain also moved to the left hand. My hands were so weak that I had trouble opening a bottle of water; I had to use a knife to break the seal before I could twist off the top. Not only that, but my hand even hurt when I held my toothbrush while brushing my teeth. I decided that I needed to do something. I tried different things to treat the pain, such as EPSOM salts and ALEVE. The ALEVE helped, but I didn't want to take it on a regular basis. My fingers were swollen, and my knuckles were huge. On 4/28/2021, I went to a medical center to see an orthopedic doctor about my hands. He suggested giving me a steroid shot, but I didn't want to go that route. He gave me some literature about arthritis of the thumb and recommended that I take TYLENOL every 8 hours. He also said I could take ALEVE whenever the pain was more intense, but a topical cream if necessary. He told me to call back if there was no improvement. It was then that I decided to try an acupuncturist. I went to the acupuncturist 5 days a week for about a month during June and July 2021. My hands dramatically improved, and I would say that they are now about 98% better. I can now open a bottle with no trouble, and I now just occasionally have joint pain in my hands. However, I began having pain in both shoulders in mid-September 2021. On 9/28/2021, I went back to the medical center to see the doctor. He took X-rays and found that I had inflammation in both rotator cuffs. He referred me to a physical therapist, whom I have been seeing once a week ever since. I was also given exercises to do at home. It has helped some, but it has been a long, slow process. If it doesn't improve further, I may have to go back to the orthopedic doctor for more suggestions.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, X-ray abnormal
Clinical narrative: I received my second dose of Moderna on 3/9/2021. On about 3/23/2021 at some time in the morning, I had pain in both hands. At first, the pain was more intense in the right hand, but over time the pain also moved to the left hand. My hands were so weak that I had trouble opening a bottle of water; I had to use a knife to break the seal before I could twist off the top. Not only that, but my hand even hurt when I held my toothbrush while brushing my teeth. I decided that I needed to do something. I tried different things to treat the pain, such as EPSOM salts and ALEVE. The ALEVE helped, but I didn't want to take it on a regular basis. My fingers were swollen, and my knuckles were huge. On 4/28/2021, I went to a medical center to see an orthopedic doctor about my hands. He suggested giving me a steroid shot, but I didn't want to go that route. He gave me some literature about arthritis of the thumb and recommended that I take TYLENOL every 8 hours. He also said I could take ALEVE whenever the pain was more intense, but a topical cream if necessary. He told me to call back if there was no improvement. It was then that I decided to try an acupuncturist. I went to the acupuncturist 5 days a week for about a month during June and July 2021. My hands dramatically improved, and I would say that they are now about 98% better. I can now open a bottle with no trouble, and I now just occasionally have joint pain in my hands. However, I began having pain in both shoulders in mid-September 2021. On 9/28/2021, I went back to the medical center to see the doctor. He took X-rays and found that I had inflammation in both rotator cuffs. He referred me to a physical therapist, whom I have been seeing once a week ever since. I was also given exercises to do at home. It has helped some, but it has been a long, slow process. If it doesn't improve further, I may have to go back to the orthopedic doctor for more suggestions.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient presented to the office for his Moderna booster vaccine (0.25 mL). It was brought to the attention of the vaccine manager, that the efficacy of the vaccines being administered that morning was diminished due to the length of time that the vaccine vial had been open for. The vial had been open for 24 hours at that point in time. The patient stayed under standard observation for 15 minutes and exhibited no ill effects.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea, Heavy menstrual bleeding
Clinical narrative: My period completely stopped immediately after the vaccine. I had no menstrual bleeding at all in the month of May or June 2021. Prior to the vaccine I was on a regular cycle for over 3 years with regular periods. At the beginning of July I started bleeding every day and it has continued now through December with no more than one day here or there of it stopping. In the last 15 days the bleeding has been heavier than I have ever bleed in my 40 years.  It has now been nearly 6 months that my body has been bleeding daily.....
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urine present, Culture urine, Cystitis, Pain
Clinical narrative: Five days after I got the second dose of the vaccine I got a Bladder infection. I noticed blood in my Urine and it was painful. I had not had a Bladder infection for many years with the exception of one right after the first dose of the vaccine. I also came down with Bronchitis the day after getting my first dose of the vaccine. I had also gotten a Bladder infection within the first week of the first dose of the vaccine. Before my vaccines I had not had a Bladder infection for about 25 years. Both infections were treated and resolved with antibiotics.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE STORED AT IMPROPER TEMPERATURES.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Covid positive contact unknown
Age: 1.17
Sex: F
Vaccine: FLU4
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Dose 1 and dose 2 of flu vaccine are supposed to be given 1 month apart. Dose 2 of flu vaccine given 11 day after dose 1. Patient is asymptomatic.
Age: 33.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Chest pain, Chills, Dyspnoea, Echocardiogram, Fatigue
Clinical narrative: 11/28/21 - chills, fatigue, body aches 11/29/21 - chills fatigue, body aches 11/30/21 - chest pain, shortness of breath, pleuritic chest pain 12/1/21 - chest pain resolved
Age: 33.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Pain, Pleuritic pain, Troponin increased
Clinical narrative: 11/28/21 - chills, fatigue, body aches 11/29/21 - chills fatigue, body aches 11/30/21 - chest pain, shortness of breath, pleuritic chest pain 12/1/21 - chest pain resolved
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Patient received first Pfizer booster at vaccination site. During observation period, patient told medic she was experiencing pruritus in the arm she received the shot in as well as other areas of her body. She had the same reaction after both of her primary series vaccinations and it was relieved with PO Benadryl. Patient was given 25mL of PO Benadryl by on-site paramedic, symptoms relieved 30 minutes after vaccination and left. Reported by on-site paramedic and staff.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Incorrect dose administered
Clinical narrative: Incorrect Dose Moderna booster dose administered was 0.5 milliliters. Booster dose should have been 0.25 milliliters.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: Uticaria. Random itchy hives and rashes all over various parts of my body, coming and going at varying intervals
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Extra dose administered, Wrong technique in product usage process
Clinical narrative: Patient presented to the office for her Moderna booster vaccine (0.25 mL). It was brought to the attention of the vaccine manager, that the efficacy of the vaccines being administered that morning was diminished due to the length of time that the vaccine vial had been open for. The vial had been open for 24 hours at that point in time. The patient stayed under standard observation for 15 minutes and exhibited no ill effects.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vital signs measurement
Clinical narrative: Asymptomatic but according to her apple watch, her heart rate went up  to 100 to 120 from the hour of 10 pm to 11 pm the day after getting the vaccine. The patient showed me the record of the out of range number at the pharmacy.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Fatigue, Pain in extremity, Palpitations
Clinical narrative: Sore arm, fatigue, dizziness, heart palpitations, tachycardia, chest pain
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Sore arm, fatigue, dizziness, heart palpitations, tachycardia, chest pain
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: COVID-19 positive; contact unknown.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Alanine aminotransferase normal, Anion gap normal, Aspartate aminotransferase increased, Asthenia
Clinical narrative: Mortality of fully vaccinated patient Patient presented on 11/20/2021 with complaints of weakness and dyspnea after being diagnosed with COVID-19 on 11/16.  She had been being treated as an outpatient with supplemental oxygen and dexamethasone.   She was also being treated for urinary tract infection.  supplemental oxygen requirements in the ED were  only 4-5 L nasal cannula however upon admission and transfer to the CCU oxygen requirements went up to 15 L high-flow with variable saturations in the mid 80s to mid 90s.  Due to this rapid change in O2 requirements the patient was then a candidate for additional COVID-19 treatments under the experimental protocols.  After discussing the risks and benefits with the patient she requested to proceed with treatment using baricitinib and remdesivir.   Initial hypoxia  prior to presentation resulted in a type 2 MI,  cardiology was consulted,  and echocardiogram was obtained.  Repeat echocardiogram performed 3 days later showed significant improvement and resolution of initial injury.   Over the next couple days the patient's oxygen requirements continued to increase and she was begun on Airvo and then BiPAP.   The patient declined intubation upon presentation should that become necessary.  The patient tired of the BiPAP and requested for us to call her children to come in and make a family decision regarding the next steps in her care.   Patient and family agreed to go comfort measures,  the family gathered around and the patient was taken off of supplemental oxygen,  and passed peacefully.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Basophil count decreased, Blood albumin decreased, Blood alkaline phosphatase normal, Blood bicarbonate normal, Blood bilirubin decreased
Clinical narrative: Mortality of fully vaccinated patient Patient presented on 11/20/2021 with complaints of weakness and dyspnea after being diagnosed with COVID-19 on 11/16.  She had been being treated as an outpatient with supplemental oxygen and dexamethasone.   She was also being treated for urinary tract infection.  supplemental oxygen requirements in the ED were  only 4-5 L nasal cannula however upon admission and transfer to the CCU oxygen requirements went up to 15 L high-flow with variable saturations in the mid 80s to mid 90s.  Due to this rapid change in O2 requirements the patient was then a candidate for additional COVID-19 treatments under the experimental protocols.  After discussing the risks and benefits with the patient she requested to proceed with treatment using baricitinib and remdesivir.   Initial hypoxia  prior to presentation resulted in a type 2 MI,  cardiology was consulted,  and echocardiogram was obtained.  Repeat echocardiogram performed 3 days later showed significant improvement and resolution of initial injury.   Over the next couple days the patient's oxygen requirements continued to increase and she was begun on Airvo and then BiPAP.   The patient declined intubation upon presentation should that become necessary.  The patient tired of the BiPAP and requested for us to call her children to come in and make a family decision regarding the next steps in her care.   Patient and family agreed to go comfort measures,  the family gathered around and the patient was taken off of supplemental oxygen,  and passed peacefully.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Blood calcium decreased, Blood chloride increased, Blood creatinine increased, Blood gases, Blood glucose normal
Clinical narrative: Mortality of fully vaccinated patient Patient presented on 11/20/2021 with complaints of weakness and dyspnea after being diagnosed with COVID-19 on 11/16.  She had been being treated as an outpatient with supplemental oxygen and dexamethasone.   She was also being treated for urinary tract infection.  supplemental oxygen requirements in the ED were  only 4-5 L nasal cannula however upon admission and transfer to the CCU oxygen requirements went up to 15 L high-flow with variable saturations in the mid 80s to mid 90s.  Due to this rapid change in O2 requirements the patient was then a candidate for additional COVID-19 treatments under the experimental protocols.  After discussing the risks and benefits with the patient she requested to proceed with treatment using baricitinib and remdesivir.   Initial hypoxia  prior to presentation resulted in a type 2 MI,  cardiology was consulted,  and echocardiogram was obtained.  Repeat echocardiogram performed 3 days later showed significant improvement and resolution of initial injury.   Over the next couple days the patient's oxygen requirements continued to increase and she was begun on Airvo and then BiPAP.   The patient declined intubation upon presentation should that become necessary.  The patient tired of the BiPAP and requested for us to call her children to come in and make a family decision regarding the next steps in her care.   Patient and family agreed to go comfort measures,  the family gathered around and the patient was taken off of supplemental oxygen,  and passed peacefully.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Blood lactic acid decreased, Blood osmolarity normal, Blood pH normal, Blood potassium normal, Blood sodium normal
Clinical narrative: Mortality of fully vaccinated patient Patient presented on 11/20/2021 with complaints of weakness and dyspnea after being diagnosed with COVID-19 on 11/16.  She had been being treated as an outpatient with supplemental oxygen and dexamethasone.   She was also being treated for urinary tract infection.  supplemental oxygen requirements in the ED were  only 4-5 L nasal cannula however upon admission and transfer to the CCU oxygen requirements went up to 15 L high-flow with variable saturations in the mid 80s to mid 90s.  Due to this rapid change in O2 requirements the patient was then a candidate for additional COVID-19 treatments under the experimental protocols.  After discussing the risks and benefits with the patient she requested to proceed with treatment using baricitinib and remdesivir.   Initial hypoxia  prior to presentation resulted in a type 2 MI,  cardiology was consulted,  and echocardiogram was obtained.  Repeat echocardiogram performed 3 days later showed significant improvement and resolution of initial injury.   Over the next couple days the patient's oxygen requirements continued to increase and she was begun on Airvo and then BiPAP.   The patient declined intubation upon presentation should that become necessary.  The patient tired of the BiPAP and requested for us to call her children to come in and make a family decision regarding the next steps in her care.   Patient and family agreed to go comfort measures,  the family gathered around and the patient was taken off of supplemental oxygen,  and passed peacefully.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urea increased, Blood urea nitrogen/creatinine ratio, C-reactive protein increased, COVID-19, Carbon dioxide decreased
Clinical narrative: Mortality of fully vaccinated patient Patient presented on 11/20/2021 with complaints of weakness and dyspnea after being diagnosed with COVID-19 on 11/16.  She had been being treated as an outpatient with supplemental oxygen and dexamethasone.   She was also being treated for urinary tract infection.  supplemental oxygen requirements in the ED were  only 4-5 L nasal cannula however upon admission and transfer to the CCU oxygen requirements went up to 15 L high-flow with variable saturations in the mid 80s to mid 90s.  Due to this rapid change in O2 requirements the patient was then a candidate for additional COVID-19 treatments under the experimental protocols.  After discussing the risks and benefits with the patient she requested to proceed with treatment using baricitinib and remdesivir.   Initial hypoxia  prior to presentation resulted in a type 2 MI,  cardiology was consulted,  and echocardiogram was obtained.  Repeat echocardiogram performed 3 days later showed significant improvement and resolution of initial injury.   Over the next couple days the patient's oxygen requirements continued to increase and she was begun on Airvo and then BiPAP.   The patient declined intubation upon presentation should that become necessary.  The patient tired of the BiPAP and requested for us to call her children to come in and make a family decision regarding the next steps in her care.   Patient and family agreed to go comfort measures,  the family gathered around and the patient was taken off of supplemental oxygen,  and passed peacefully.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Echocardiogram abnormal, Eosinophil count decreased, Eosinophil percentage decreased
Clinical narrative: Mortality of fully vaccinated patient Patient presented on 11/20/2021 with complaints of weakness and dyspnea after being diagnosed with COVID-19 on 11/16.  She had been being treated as an outpatient with supplemental oxygen and dexamethasone.   She was also being treated for urinary tract infection.  supplemental oxygen requirements in the ED were  only 4-5 L nasal cannula however upon admission and transfer to the CCU oxygen requirements went up to 15 L high-flow with variable saturations in the mid 80s to mid 90s.  Due to this rapid change in O2 requirements the patient was then a candidate for additional COVID-19 treatments under the experimental protocols.  After discussing the risks and benefits with the patient she requested to proceed with treatment using baricitinib and remdesivir.   Initial hypoxia  prior to presentation resulted in a type 2 MI,  cardiology was consulted,  and echocardiogram was obtained.  Repeat echocardiogram performed 3 days later showed significant improvement and resolution of initial injury.   Over the next couple days the patient's oxygen requirements continued to increase and she was begun on Airvo and then BiPAP.   The patient declined intubation upon presentation should that become necessary.  The patient tired of the BiPAP and requested for us to call her children to come in and make a family decision regarding the next steps in her care.   Patient and family agreed to go comfort measures,  the family gathered around and the patient was taken off of supplemental oxygen,  and passed peacefully.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Glomerular filtration rate decreased, Haematocrit decreased, Haemoglobin decreased, Hypoxia, Immature granulocyte count
Clinical narrative: Mortality of fully vaccinated patient Patient presented on 11/20/2021 with complaints of weakness and dyspnea after being diagnosed with COVID-19 on 11/16.  She had been being treated as an outpatient with supplemental oxygen and dexamethasone.   She was also being treated for urinary tract infection.  supplemental oxygen requirements in the ED were  only 4-5 L nasal cannula however upon admission and transfer to the CCU oxygen requirements went up to 15 L high-flow with variable saturations in the mid 80s to mid 90s.  Due to this rapid change in O2 requirements the patient was then a candidate for additional COVID-19 treatments under the experimental protocols.  After discussing the risks and benefits with the patient she requested to proceed with treatment using baricitinib and remdesivir.   Initial hypoxia  prior to presentation resulted in a type 2 MI,  cardiology was consulted,  and echocardiogram was obtained.  Repeat echocardiogram performed 3 days later showed significant improvement and resolution of initial injury.   Over the next couple days the patient's oxygen requirements continued to increase and she was begun on Airvo and then BiPAP.   The patient declined intubation upon presentation should that become necessary.  The patient tired of the BiPAP and requested for us to call her children to come in and make a family decision regarding the next steps in her care.   Patient and family agreed to go comfort measures,  the family gathered around and the patient was taken off of supplemental oxygen,  and passed peacefully.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Intensive care, Lymphocyte count decreased, Lymphocyte percentage decreased, Mean cell haemoglobin concentration normal, Mean cell haemoglobin increased
Clinical narrative: Mortality of fully vaccinated patient Patient presented on 11/20/2021 with complaints of weakness and dyspnea after being diagnosed with COVID-19 on 11/16.  She had been being treated as an outpatient with supplemental oxygen and dexamethasone.   She was also being treated for urinary tract infection.  supplemental oxygen requirements in the ED were  only 4-5 L nasal cannula however upon admission and transfer to the CCU oxygen requirements went up to 15 L high-flow with variable saturations in the mid 80s to mid 90s.  Due to this rapid change in O2 requirements the patient was then a candidate for additional COVID-19 treatments under the experimental protocols.  After discussing the risks and benefits with the patient she requested to proceed with treatment using baricitinib and remdesivir.   Initial hypoxia  prior to presentation resulted in a type 2 MI,  cardiology was consulted,  and echocardiogram was obtained.  Repeat echocardiogram performed 3 days later showed significant improvement and resolution of initial injury.   Over the next couple days the patient's oxygen requirements continued to increase and she was begun on Airvo and then BiPAP.   The patient declined intubation upon presentation should that become necessary.  The patient tired of the BiPAP and requested for us to call her children to come in and make a family decision regarding the next steps in her care.   Patient and family agreed to go comfort measures,  the family gathered around and the patient was taken off of supplemental oxygen,  and passed peacefully.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Mean cell volume normal, Mean platelet volume normal, Monocyte count normal, Monocyte percentage, Neutrophil count normal
Clinical narrative: Mortality of fully vaccinated patient Patient presented on 11/20/2021 with complaints of weakness and dyspnea after being diagnosed with COVID-19 on 11/16.  She had been being treated as an outpatient with supplemental oxygen and dexamethasone.   She was also being treated for urinary tract infection.  supplemental oxygen requirements in the ED were  only 4-5 L nasal cannula however upon admission and transfer to the CCU oxygen requirements went up to 15 L high-flow with variable saturations in the mid 80s to mid 90s.  Due to this rapid change in O2 requirements the patient was then a candidate for additional COVID-19 treatments under the experimental protocols.  After discussing the risks and benefits with the patient she requested to proceed with treatment using baricitinib and remdesivir.   Initial hypoxia  prior to presentation resulted in a type 2 MI,  cardiology was consulted,  and echocardiogram was obtained.  Repeat echocardiogram performed 3 days later showed significant improvement and resolution of initial injury.   Over the next couple days the patient's oxygen requirements continued to increase and she was begun on Airvo and then BiPAP.   The patient declined intubation upon presentation should that become necessary.  The patient tired of the BiPAP and requested for us to call her children to come in and make a family decision regarding the next steps in her care.   Patient and family agreed to go comfort measures,  the family gathered around and the patient was taken off of supplemental oxygen,  and passed peacefully.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Neutrophil percentage increased, Oxygen saturation decreased, PCO2 normal, Platelet count decreased, Positive airway pressure therapy
Clinical narrative: Mortality of fully vaccinated patient Patient presented on 11/20/2021 with complaints of weakness and dyspnea after being diagnosed with COVID-19 on 11/16.  She had been being treated as an outpatient with supplemental oxygen and dexamethasone.   She was also being treated for urinary tract infection.  supplemental oxygen requirements in the ED were  only 4-5 L nasal cannula however upon admission and transfer to the CCU oxygen requirements went up to 15 L high-flow with variable saturations in the mid 80s to mid 90s.  Due to this rapid change in O2 requirements the patient was then a candidate for additional COVID-19 treatments under the experimental protocols.  After discussing the risks and benefits with the patient she requested to proceed with treatment using baricitinib and remdesivir.   Initial hypoxia  prior to presentation resulted in a type 2 MI,  cardiology was consulted,  and echocardiogram was obtained.  Repeat echocardiogram performed 3 days later showed significant improvement and resolution of initial injury.   Over the next couple days the patient's oxygen requirements continued to increase and she was begun on Airvo and then BiPAP.   The patient declined intubation upon presentation should that become necessary.  The patient tired of the BiPAP and requested for us to call her children to come in and make a family decision regarding the next steps in her care.   Patient and family agreed to go comfort measures,  the family gathered around and the patient was taken off of supplemental oxygen,  and passed peacefully.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Protein total normal, Red blood cell count decreased, Red blood cell nucleated morphology, Red cell distribution width normal, Troponin I increased
Clinical narrative: Mortality of fully vaccinated patient Patient presented on 11/20/2021 with complaints of weakness and dyspnea after being diagnosed with COVID-19 on 11/16.  She had been being treated as an outpatient with supplemental oxygen and dexamethasone.   She was also being treated for urinary tract infection.  supplemental oxygen requirements in the ED were  only 4-5 L nasal cannula however upon admission and transfer to the CCU oxygen requirements went up to 15 L high-flow with variable saturations in the mid 80s to mid 90s.  Due to this rapid change in O2 requirements the patient was then a candidate for additional COVID-19 treatments under the experimental protocols.  After discussing the risks and benefits with the patient she requested to proceed with treatment using baricitinib and remdesivir.   Initial hypoxia  prior to presentation resulted in a type 2 MI,  cardiology was consulted,  and echocardiogram was obtained.  Repeat echocardiogram performed 3 days later showed significant improvement and resolution of initial injury.   Over the next couple days the patient's oxygen requirements continued to increase and she was begun on Airvo and then BiPAP.   The patient declined intubation upon presentation should that become necessary.  The patient tired of the BiPAP and requested for us to call her children to come in and make a family decision regarding the next steps in her care.   Patient and family agreed to go comfort measures,  the family gathered around and the patient was taken off of supplemental oxygen,  and passed peacefully.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection, White blood cell count normal
Clinical narrative: Mortality of fully vaccinated patient Patient presented on 11/20/2021 with complaints of weakness and dyspnea after being diagnosed with COVID-19 on 11/16.  She had been being treated as an outpatient with supplemental oxygen and dexamethasone.   She was also being treated for urinary tract infection.  supplemental oxygen requirements in the ED were  only 4-5 L nasal cannula however upon admission and transfer to the CCU oxygen requirements went up to 15 L high-flow with variable saturations in the mid 80s to mid 90s.  Due to this rapid change in O2 requirements the patient was then a candidate for additional COVID-19 treatments under the experimental protocols.  After discussing the risks and benefits with the patient she requested to proceed with treatment using baricitinib and remdesivir.   Initial hypoxia  prior to presentation resulted in a type 2 MI,  cardiology was consulted,  and echocardiogram was obtained.  Repeat echocardiogram performed 3 days later showed significant improvement and resolution of initial injury.   Over the next couple days the patient's oxygen requirements continued to increase and she was begun on Airvo and then BiPAP.   The patient declined intubation upon presentation should that become necessary.  The patient tired of the BiPAP and requested for us to call her children to come in and make a family decision regarding the next steps in her care.   Patient and family agreed to go comfort measures,  the family gathered around and the patient was taken off of supplemental oxygen,  and passed peacefully.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine increased, Blood glucose increased, Blood magnesium normal, Blood sodium decreased, Chest discomfort
Clinical narrative: This is a 59y.o. male with hx of asthma, COPD, HTN, BPH, heart valve replacement who presents to hospital with a chief complaint of shortness of breath with chest pain. Pt states that he has been having a cough for the past 2 weeks which has been progressively getting worse. Pt states that he has had a headache with the coughs that has been getting worse as well but has been untreatable. Pt claims that he has been having diarrhea for the past 2-3 days which was yellow in color. Pt states that his chest pain has been occurring for the past week but only occurs with coughing. Pt states that he smoked 1ppd for 10 years but quit 2 years ago. Pt states that he drinks 2-3 16oz beers everyday. Pt was complaining of a balloon feeling on his left chest.     Upon arrival to the ED:  o Vitals: T 100.5°F, BP 166/105, HR 102, RR 18, SpO2 98% on RA.  o EKG demonstrates Sinus tachycardia  o Lab work obtained and remarkable for:  ? CBC - 14.5 WBC, 5.87 RBC, 17.2 Hgb, Platelet 136 ? BMP - hyponatremia (130), Hypochloremia, creatinine 2.10, GFR 39, Glucose 126 ? Mag 1.4 ? Protein total 8.4  ? + Legionella urine culture  o Imaging demonstrates: no acute process o Patient given azithromycin
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Cough, Culture urine positive, Diarrhoea, Dyspnoea
Clinical narrative: This is a 59y.o. male with hx of asthma, COPD, HTN, BPH, heart valve replacement who presents to hospital with a chief complaint of shortness of breath with chest pain. Pt states that he has been having a cough for the past 2 weeks which has been progressively getting worse. Pt states that he has had a headache with the coughs that has been getting worse as well but has been untreatable. Pt claims that he has been having diarrhea for the past 2-3 days which was yellow in color. Pt states that his chest pain has been occurring for the past week but only occurs with coughing. Pt states that he smoked 1ppd for 10 years but quit 2 years ago. Pt states that he drinks 2-3 16oz beers everyday. Pt was complaining of a balloon feeling on his left chest.     Upon arrival to the ED:  o Vitals: T 100.5°F, BP 166/105, HR 102, RR 18, SpO2 98% on RA.  o EKG demonstrates Sinus tachycardia  o Lab work obtained and remarkable for:  ? CBC - 14.5 WBC, 5.87 RBC, 17.2 Hgb, Platelet 136 ? BMP - hyponatremia (130), Hypochloremia, creatinine 2.10, GFR 39, Glucose 126 ? Mag 1.4 ? Protein total 8.4  ? + Legionella urine culture  o Imaging demonstrates: no acute process o Patient given azithromycin
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal, Faeces discoloured, Full blood count, Glomerular filtration rate decreased, Haemoglobin
Clinical narrative: This is a 59y.o. male with hx of asthma, COPD, HTN, BPH, heart valve replacement who presents to hospital with a chief complaint of shortness of breath with chest pain. Pt states that he has been having a cough for the past 2 weeks which has been progressively getting worse. Pt states that he has had a headache with the coughs that has been getting worse as well but has been untreatable. Pt claims that he has been having diarrhea for the past 2-3 days which was yellow in color. Pt states that his chest pain has been occurring for the past week but only occurs with coughing. Pt states that he smoked 1ppd for 10 years but quit 2 years ago. Pt states that he drinks 2-3 16oz beers everyday. Pt was complaining of a balloon feeling on his left chest.     Upon arrival to the ED:  o Vitals: T 100.5°F, BP 166/105, HR 102, RR 18, SpO2 98% on RA.  o EKG demonstrates Sinus tachycardia  o Lab work obtained and remarkable for:  ? CBC - 14.5 WBC, 5.87 RBC, 17.2 Hgb, Platelet 136 ? BMP - hyponatremia (130), Hypochloremia, creatinine 2.10, GFR 39, Glucose 126 ? Mag 1.4 ? Protein total 8.4  ? + Legionella urine culture  o Imaging demonstrates: no acute process o Patient given azithromycin
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hypochloraemia, Hyponatraemia, Legionella test positive, Metabolic function test
Clinical narrative: This is a 59y.o. male with hx of asthma, COPD, HTN, BPH, heart valve replacement who presents to hospital with a chief complaint of shortness of breath with chest pain. Pt states that he has been having a cough for the past 2 weeks which has been progressively getting worse. Pt states that he has had a headache with the coughs that has been getting worse as well but has been untreatable. Pt claims that he has been having diarrhea for the past 2-3 days which was yellow in color. Pt states that his chest pain has been occurring for the past week but only occurs with coughing. Pt states that he smoked 1ppd for 10 years but quit 2 years ago. Pt states that he drinks 2-3 16oz beers everyday. Pt was complaining of a balloon feeling on his left chest.     Upon arrival to the ED:  o Vitals: T 100.5°F, BP 166/105, HR 102, RR 18, SpO2 98% on RA.  o EKG demonstrates Sinus tachycardia  o Lab work obtained and remarkable for:  ? CBC - 14.5 WBC, 5.87 RBC, 17.2 Hgb, Platelet 136 ? BMP - hyponatremia (130), Hypochloremia, creatinine 2.10, GFR 39, Glucose 126 ? Mag 1.4 ? Protein total 8.4  ? + Legionella urine culture  o Imaging demonstrates: no acute process o Patient given azithromycin
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Platelet count decreased, Protein total increased, Red blood cell count increased, Sinus tachycardia, White blood cell count normal
Clinical narrative: This is a 59y.o. male with hx of asthma, COPD, HTN, BPH, heart valve replacement who presents to hospital with a chief complaint of shortness of breath with chest pain. Pt states that he has been having a cough for the past 2 weeks which has been progressively getting worse. Pt states that he has had a headache with the coughs that has been getting worse as well but has been untreatable. Pt claims that he has been having diarrhea for the past 2-3 days which was yellow in color. Pt states that his chest pain has been occurring for the past week but only occurs with coughing. Pt states that he smoked 1ppd for 10 years but quit 2 years ago. Pt states that he drinks 2-3 16oz beers everyday. Pt was complaining of a balloon feeling on his left chest.     Upon arrival to the ED:  o Vitals: T 100.5°F, BP 166/105, HR 102, RR 18, SpO2 98% on RA.  o EKG demonstrates Sinus tachycardia  o Lab work obtained and remarkable for:  ? CBC - 14.5 WBC, 5.87 RBC, 17.2 Hgb, Platelet 136 ? BMP - hyponatremia (130), Hypochloremia, creatinine 2.10, GFR 39, Glucose 126 ? Mag 1.4 ? Protein total 8.4  ? + Legionella urine culture  o Imaging demonstrates: no acute process o Patient given azithromycin
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Incorrect Dose Moderna booster dose administered was 0.5 milliliters. Booster dose should have been 0.25 milliliters.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Contusion, Epistaxis, Fatigue, Petechiae
Clinical narrative: Symptoms would have been bruising, when I blew my nose, there was blood. Petechiae and I was getting tired which meant my numbers were getting low for the ITP, platelet levels were dropping. I contacted the doctor and got my numbers checked and he gave me an injection of N-Plate and given dexamethasone. And I went back a week later to see if my numbers would go up and this has been weekly ever since. And he suggests the dosage of N-Plate depending on where my numbers are. Recovery status depends on numbers of platelet count weekly.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: Covid positive household contact
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Arm full of pain can't lift my arm normal without pain.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardiac stress test, Chest X-ray, Chest pain, Computerised tomogram thorax, Dyspnoea
Clinical narrative: chess Pains, Heart papitations, shorness of breath, fatigue.